Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dialysis
Pharma
DaVita doubts broad benefit of Novo's Ozempic in kidney disease
An apparent win for Novo Nordisk’s Ozempic in kidney disease could transform decades of treatment. But not all renal specialists are on board.
Fraiser Kansteiner
Oct 12, 2023 3:32pm
AZ targets people who don't know they have CKD in new spot
Jan 27, 2023 7:30am
After pair of losses, Ardelyx's CKD prospect finds FDA foothold
Nov 17, 2022 8:05am
FDA flags concerns about Ardelyx's kidney disease prospect
Nov 15, 2022 10:48am
Akebia gears up for key anemia launch with Vifor deal expansion
Feb 23, 2022 11:25am
Cara, Vifor win FDA nod for pruritus treatment Korsuva
Aug 23, 2021 6:37pm
